Arch Therapeutics, Inc.

Industry

  • Medical Devices
    • Biomaterials
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
      • Surgical Sealants
  • Biotechnology

Other Names/Subsidiaries

  • Arch Biosurgery, Inc.
  • Clear Nano Solutions, Inc.
See more in Biomedtracker

Latest on Arch Therapeutics, Inc.

In Vivo

Deals Shaping The Medical Industry, March 2017

 
• By Steven Muntner, Beth Allan, Deanna Kamienski, Amanda Micklus, and Maureen Riordan

IN VITRO DIAGNOSTICS Financings Vermillion Inc. Vermillion Inc. grossed $5.6mm through the private sale of 3.75mm common shares at $1.40 (a 6% premium). Investors also received five-year warrants

Medtech Insight

Arch Therapeutics Closes In On CE Mark For Novel Blood Control Agent

 
• By Reed Miller

Arch Therapeutics Inc. says it is still on track to file for a CE mark for its AC5 topical hemostatic agent by the end of 2016 – a few months later than originally planned – as preliminary data fr

Medtech Insight

Medtech Execs On The Move, October 2015

Company Changes ALATARIS , Kostantinos, PhD To: Zosano Pharma Corp. , Pres. & COO (September) From: IRRAS AB, Exec. Chairman Phone: 510-745-1200 BARTH , Neil M., MD To: Veracyte Inc. , CMO

Medtech Insight

Medical Device Deals Update, June-July 2015

Strategic Transactions